PD-1 blockade in combination with zoledronic acid to enhance the antitumor efficacy in the breast cancer mouse model

被引：0
|
作者：
Li, Yuan
Du, Yang
Sun, Ting
Xue, Huadan
Tian, Jie
Jin, Zhengyu
机构：
来源：
CANCER RESEARCH | 2017年 / 77卷
关键词：
D O I：
10.1158/1538-7445.AM2017-2660
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2660
引用
收藏
页数：2
相关论文
共 50 条
  • [1] PD-1 blockade in combination with zoledronic acid to enhance the antitumor efficacy in the breast cancer mouse model
    Yuan Li
    Yang Du
    Ting Sun
    Huadan Xue
    Zhengyu Jin
    Jie Tian
    BMC Cancer, 18
  • [2] PD-1 blockade in combination with zoledronic acid to enhance the antitumor efficacy in the breast cancer mouse model
    Li, Yuan
    Du, Yang
    Sun, Ting
    Xue, Huadan
    Jin, Zhengyu
    Tian, Jie
    BMC CANCER, 2018, 18
  • [3] COMBINATION OF VEGF-A AND PD-1 BLOCKADE MAY ENHANCE ANTITUMOR EFFICACY IN GBM
    Long, Yu
    Yang, Changlin
    Jin, Linchun
    Ge, Haitao
    Bao, Hongbo
    Flores, Catherine
    Lin, Zhiguo
    Mitchell, Duane
    Huang, Jianping
    NEURO-ONCOLOGY, 2016, 18 : 91 - 91
  • [4] The Novel Combination of Nitroxoline and PD-1 Blockade, Exerts a Potent Antitumor Effect in a Mouse Model of Prostate Cancer
    Xu, Naijin
    Huang, Linglong
    Li, Xiezhao
    Watanabela, Masami
    Li, Chaoming
    Xu, Abai
    Liu, Chunxiao
    Li, Qiang
    Araki, Motoo
    Wada, Koichiro
    Nasu, Yasutomo
    Huang, Peng
    INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2019, 15 (05): : 919 - 928
  • [5] PD-1 Blockade Enhances the Efficacy of Chemoradiation in a Mouse Model of Esophageal Cancer
    Oh, P.
    Du, K. L.
    Leichman, L.
    Aifantis, I.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : S127 - S128
  • [6] Combination Immunotherapy with 4-1BB Activation and PD-1 Blockade Enhances Antitumor Efficacy in a Mouse Model of Subcutaneous Tumor
    Shindo, Yoshitaro
    Yoshimura, Kiyoshi
    Kuramasu, Atsuo
    Watanabe, Yusaku
    Ito, Hideaki
    Kondo, Tomoko
    Oga, Atsunori
    Ito, Hiroshi
    Yoshino, Shigefumi
    Hazama, Shoichi
    Tamada, Koji
    Yagita, Hideo
    Oka, Masaaki
    ANTICANCER RESEARCH, 2015, 35 (01) : 129 - 136
  • [7] Combination TIGIT/PD-1 blockade enhances the efficacy of neoantigen vaccines in a model of pancreatic cancer
    Peng, Hui
    Li, Lijin
    Zuo, Chong
    Chen, Michael Y.
    Zhang, Xiuli
    Myers, Nancy B.
    Hogg, Graham D.
    DeNardo, David G.
    Goedegebuure, S. Peter
    Hawkins, William G.
    Gillanders, William E.
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [8] Antitumor effects of doxorubicin followed by zoledronic acid in a mouse model of breast cancer
    Ottewell, Penelope D.
    Monkkonen, Hannu
    Jones, Mark
    Lefley, Diane V.
    Coleman, Robert E.
    Holen, Ingunn
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2008, 100 (16): : 1167 - 1178
  • [9] A Combination of PD-1 and TIGIT Checkpoint Blockade Elicits a Strong Antitumor Response in the Patient and Mouse Pleural Mesothelioma Model
    Shi, H.
    Johnson, B.
    Yu, T. -K.
    Zhuang, L.
    Selvamani, S. P.
    Lee, K.
    Klebe, S.
    Chen, K.
    Clark, G.
    Kao, S.
    Silveira, P.
    Cheng, Y. Y.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S388 - S388
  • [10] Targeting metabolic vulnerabilities of MDSCs to enhance the antitumor activity of PD-1 blockade
    Kim, Sun Hye
    Li, Man
    Trousil, Sebastian
    Zheng, Bin
    CANCER IMMUNOLOGY RESEARCH, 2018, 6 (09)
12345